NovaBay Pharmaceuticals Inc (NBY) Annual Income Statement (USD)
NBY Quarterly Financials (USD)
Frequently Asked Questions About NovaBay Pharmaceuticals Inc (NBY) Stock
NovaBay Pharmaceuticals Inc's (NBY) last reported annual revenue was USD 14.73 Million.
NovaBay Pharmaceuticals Inc's (NBY) annual revenue growth rate based on the revenue reported in the past 5 years is : 3.32%
NovaBay Pharmaceuticals Inc's(NBY) is not profitable as of its last reported annual financials.
The net profit margin for NovaBay Pharmaceuticals Inc's(NBY) from its laster reported year is -65.46%
The return on equity (ROE) for NovaBay Pharmaceuticals Inc's(NBY) from its last reported annual financials is : -139.03%
The return on assets (ROA) for NovaBay Pharmaceuticals Inc's(NBY) from its last reported annual financials is : -24.59%
The return on invested capital (ROIC) for NovaBay Pharmaceuticals Inc's(NBY) from its last reported annual financials is : -66.68%
The Debt to Equity ratio for NovaBay Pharmaceuticals Inc's(NBY) from its last reported annual financials is : 0.00%
The dividend yield for NovaBay Pharmaceuticals Inc's(NBY) from its laster reported year is 0.00%
NovaBay Pharmaceuticals Inc's(NBY) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NBY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
